Ladics G S, Smith C, Heaps K, Elliott G S, Slone T W, Loveless S E
E.I. du Pont de Nemours and Co., Haskell Laboratory for Toxicology and Industrial Medicine, Newark, DE 19714.
Toxicology. 1995 Feb 27;96(3):225-38. doi: 10.1016/0300-483x(94)02967-y.
The objective of this study was to examine the feasibility of conducting an immunotoxicological assay for assessing humoral immunity in rats on standard toxicology study. Male CD rats were untreated or dosed intraperitoneally daily for 30 or 90 days, excluding weekends, with vehicle or 2 mg/kg cyclophosphamide (CY). Six days prior to sacrifice, selected rats were injected intravenously with sheep red blood cells (SRBC). One day prior to necropsy, blood samples for hematological and clinical chemical measurements were collected from each rat. On the day of necropsy standard protocol tissues were collected, weighed, processed to slides, and examined microscopically. One-half of each spleen was used to prepare a single cell suspension in order to assess spleen cell numbers. Serum was analyzed for anti-SRBC IgM antibody using an enzyme-linked immunosorbent assay. A second set of studies was performed to examine further the effect of SRBC administration on lymphoid organ weights using 30- and 90-day study age-equivalent naive male CD rats. Exposure of animals to 2 mg/kg CY for 30 or 90 days resulted in a 28% and 61% decrease, respectively, in SRBC-specific serum IgM levels. CY treatment also caused mild alterations in some leukocytic parameters, with significant decreases of 35% and 33% in white blood cell and lymphocyte counts, respectively, observed in 30-day CY-treated animals receiving SRBC. Injection of SRBC alone did not alter hematological or clinical chemistry parameters. With the expected exception of the spleen (increased number and size of germinal centers), administration of SRBC did not significantly alter the weights or morphology of routine protocol tissues. Furthermore, administration of SRBC did not mask the immunosuppressive effects of CY treatment under the conditions of this study. Based on our preliminary findings, a functional assay for assessing humoral immunity may be conducted in animals on standard toxicology study.
本研究的目的是检验在标准毒理学研究中对大鼠进行免疫毒理学测定以评估体液免疫的可行性。雄性CD大鼠不进行处理或连续30天或90天(不包括周末)每天腹腔注射赋形剂或2 mg/kg环磷酰胺(CY)。在处死前6天,给选定的大鼠静脉注射绵羊红细胞(SRBC)。在尸检前1天,从每只大鼠采集血液样本进行血液学和临床化学测量。在尸检当天,收集标准方案组织,称重,制成玻片并进行显微镜检查。取每个脾脏的一半用于制备单细胞悬液以评估脾细胞数量。使用酶联免疫吸附测定法分析血清中的抗SRBC IgM抗体。进行了另一组研究,以使用30天和90天研究年龄相当的未接触过抗原的雄性CD大鼠进一步检验注射SRBC对淋巴器官重量的影响。动物暴露于2 mg/kg CY 30天或90天分别导致SRBC特异性血清IgM水平降低28%和61%。CY处理还导致一些白细胞参数出现轻微变化,在接受SRBC的30天CY处理动物中,白细胞计数和淋巴细胞计数分别显著降低35%和33%。单独注射SRBC未改变血液学或临床化学参数。除脾脏外(生发中心数量和大小增加),注射SRBC未显著改变常规方案组织的重量或形态。此外,在本研究条件下,注射SRBC未掩盖CY处理的免疫抑制作用。基于我们的初步研究结果,在标准毒理学研究的动物中可进行评估体液免疫的功能测定。